Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.76M | 28.20M | 11.58M | 18.69M | 24.29M |
| Total Receivables | 192.00K | 157.00K | 1.13M | 258.00K | 512.00K |
| Inventory | 207.00K | 382.00K | 446.00K | 471.00K | 693.00K |
| Prepaid Expenses | 1.66M | 1.05M | 1.42M | 1.24M | 1.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 729.00K | 729.00K | 729.00K | 729.00K | -- |
| Total Current Assets | 20.54M | 30.52M | 15.31M | 21.39M | 26.84M |
|
|
|||||
| Total Current Assets | 20.54M | 30.52M | 15.31M | 21.39M | 26.84M |
| Net Property, Plant & Equipment | 8.10M | 8.91M | 9.25M | 6.49M | 6.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00 | 14.60M | 14.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 799.00K | 999.00K | 1.20M | 1.46M | 2.40M |
| Total Assets | 29.44M | 40.43M | 25.76M | 43.94M | 50.52M |
|
|
|||||
| Total Accounts Payable | 1.87M | 1.62M | 2.54M | 1.06M | 1.28M |
| Total Accrued Expenses | 6.00M | 8.47M | 7.30M | 3.95M | 3.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.71M | 1.76M | 1.81M | 1.60M | 1.54M |
| Total Finance Division Other Current Liabilities | 706.00K | 159.00K | 428.00K | 1.06M | 689.00K |
| Total Other Current Liabilities | 706.00K | 159.00K | 428.00K | 1.06M | 689.00K |
| Total Current Liabilities | 10.29M | 12.01M | 12.08M | 7.66M | 6.65M |
|
|
|||||
| Total Current Liabilities | 10.29M | 12.01M | 12.08M | 7.66M | 6.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 915.00K | 1.31M | 1.69M | 1.53M | 1.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 39.54M | 37.81M | 43.46M | 43.94M | 40.93M |
| Total Liabilities | 50.74M | 51.12M | 57.22M | 53.13M | 49.42M |
|
|
|||||
| Common Stock & APIC | 394.95M | 394.29M | 369.21M | 368.52M | 367.97M |
| Retained Earnings | -416.31M | -405.05M | -400.76M | -377.81M | -366.95M |
| Treasury Stock & Other | 67.00K | 71.00K | 86.00K | 86.00K | 85.00K |
| Total Common Equity | -21.30M | -10.69M | -31.46M | -9.20M | 1.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.30M | -10.69M | -31.46M | -9.20M | 1.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.30M | -10.69M | -31.46M | -9.20M | 1.10M |
|
|
|||||